Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phage antibodies: filamentous phage displaying antibody variable domains
McCafferty, J., Griffiths, A. D., Winter, G., & Chiswell, D. J. (1990) · Nature · doi:10.1038/348552a0 · Cited by 2,423
Self-citationMarks, J. D., Hoogenboom, H. R., Bonnert, T. P., McCafferty, J., Griffiths, A. D., & Winter, G. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90498-u · Cited by 1,603
Self-citationHuston, J. S., Levinson, D., Mudgett-Hunter, M., Tai, M. S., Novotný, J., Margolies, M. N., Ridge, R. J., Bruccoleri, R. E., Haber, E., & Crea, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.5879 · Cited by 1,593
Making antibodies by phage display technology
Winter, G., Griffiths, A. D., Hawkins, R. E., & Hoogenboom, H. R. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.002245 · Cited by 1,573
Reshaping human antibodies for therapy
Riechmann, L., Clark, M., Waldmann, H., & Winter, G. (1988) · Nature · doi:10.1038/332323a0 · Cited by 1,562
Munro, S., & Pelham, H. R. B. (1986) · Cell · doi:10.1016/0092-8674(86)90746-4 · Cited by 1,449
Replacing the complementarity-determining regions in a human antibody with those from a mouse
Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., & Winter, G. (1986) · Nature · doi:10.1038/321522a0 · Cited by 1,406
Friguet, B., Chaffotte, A. F., Djavadi-Ohaniance, L., & Goldberg, M. E. (1985) · Journal of Immunological Methods · doi:10.1016/0022-1759(85)90044-4 · Cited by 1,234
Making antibody fragments using phage display libraries
Clackson, T., Hoogenboom, H. R., Griffiths, A. D., & Winter, G. (1991) · Nature · doi:10.1038/352624a0 · Cited by 1,203
Isolation of high affinity human antibodies directly from large synthetic repertoires.
Griffiths, A. D., Williams, S. C., Hartley, O., Tomlinson, I. M., Waterhouse, P., Crosby, W. L., Kontermann, R. E., Jones, P. T., Low, N. M., & Allison, T. J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06626.x · Cited by 962
Cited by
Development of therapeutic antibodies for the treatment of diseases
Lu, R.-M., Hwang, Y.-C., Liu, I.-J., Lee, C.-C., Tsai, H.-Z., Li, H.-J., & Wu, H.-C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0592-z · Cited by 2,085
Yeast surface display for screening combinatorial polypeptide libraries
Boder, E. T., & Wittrup, K. D. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-553 · Cited by 1,760
Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems
Terpe, K. (2003) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-002-1158-6 · Cited by 1,342
Targeting Strategies for Tissue-Specific Drug Delivery
Zhao, Z., Ukidve, A., Kim, J., & Mitragotri, S. (2020) · Cell · doi:10.1016/j.cell.2020.02.001 · Cited by 1,099
In vitro selection and evolution of functional proteins by using ribosome display
Hanes, J., & Plückthun, A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.4937 · Cited by 1,088
Development trends for human monoclonal antibody therapeutics
Nelson, A. L., Dhimolea, E., & Reichert, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3229 · Cited by 1,026
Selecting and screening recombinant antibody libraries
Hoogenboom, H. R. (2005) · Nature Biotechnology · doi:10.1038/nbt1126 · Cited by 973
Improving the efficacy of antibody-based cancer therapies
Carter, P. (2001) · Nature Reviews Cancer · doi:10.1038/35101072 · Cited by 833
scFv Antibody: Principles and Clinical Application
Ahmad, Z. A., Yeap, S. K., Ali, A. M., Ho, W. Y., Alitheen, N. B. M., & Hamid, M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/980250 · Cited by 760
Knappik, A., Ge, L., Honegger, A., Pack, P., Fischer, M., Wellnhofer, G., Hoess, A., Wölle, J., Plückthun, A., & Virnekäs, B. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3444 · Cited by 728
“…of the V H 3 germline subfamily, is also the most frequently used V H 3 germline gene (see Table 1) and it is very frequently found in antibody phage-display libraries based on human genes (Grif®ths et al., 1994; Vaughan et al., 1996; Dorsam et al., 1997; Boel et al., 1998; Sheets et al., 1998).”
BackgroundRabilloud, T. (2002) · PROTEOMICS · doi:10.1002/1615-9861(200201)2:1<3::aid-prot3>3.0.co;2-r · Cited by 717
Engineering novel binding proteins from nonimmunoglobulin domains
Binz, H. K., Amstutz, P., & Plückthun, A. (2005) · Nature Biotechnology · doi:10.1038/nbt1127 · Cited by 676
Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain
Nord, K., Gunneriusson, E., Ringdahl, J., Ståhl, S., Uhlén, M., & Nygren, P.-Å. (1997) · Nature Biotechnology · doi:10.1038/nbt0897-772 · Cited by 662
Antibody arrays for high-throughput screening of antibody–antigen interactions
de Wildt, R. M. T., Mundy, C. R., Gorick, B. D., & Tomlinson, I. M. (2000) · Nature Biotechnology · doi:10.1038/79494 · Cited by 624
Single domain camel antibodies: current status
Muyldermans, S. (2001) · Reviews in Molecular Biotechnology · doi:10.1016/s1389-0352(01)00021-6 · Cited by 552
de Haard, H. J., van Neer, N., Reurs, A., Hufton, S. E., Roovers, R. C., Henderikx, P., de Bruı̈ne, A. P., Arends, J.-W., & Hoogenboom, H. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18218 · Cited by 533
Feldhaus, M. J., Siegel, R. W., Opresko, L. K., Coleman, J. R., Feldhaus, J. M. W., Yeung, Y. A., Cochran, J. R., Heinzelman, P., Colby, D., Swers, J., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt785 · Cited by 520
Antibody phage display technology and its applications
Hoogenboom, H. R., de Bruı̈ne, A. P., Hufton, S. E., Hoet, R. M., Arends, J.-W., & Roovers, R. C. (1998) · Immunotechnology · doi:10.1016/s1380-2933(98)00007-4 · Cited by 512
Krebber, A., Bornhauser, S., Burmester, J., Honegger, A., Willuda, J., Bosshard, H. R., & Plückthun, A. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(96)00208-6 · Cited by 491
Small Bioactive Peptides for Biomaterials Design and Therapeutics
Hamley, I. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00522 · Cited by 461
Glanville, J., Zhai, W., Berka, J., Telman, D., Huerta, G., Mehta, G. R., Ni, I., Mei, L., Sundar, P. D., Day, G. M. R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909775106 · Cited by 440
Sheets, M. D., Amersdorfer, P., Finnern, R., Sargent, P., Lindqvist, E., Schier, R., Hemingsen, G., Wong, C., Gerhart, J. C., & Marks, J. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6157 · Cited by 438
Monoclonal antibody therapeutics: history and future
Buss, N. A., Henderson, S. J., McFarlane, M., Shenton, J. M., & de Haan, L. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.08.001 · Cited by 434
Design and Use of a Phage Display Library
Pini, A., Viti, F., Santucci, A., Carnemolla, B., Zardi, L., Neri, P., & Neri, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21769 · Cited by 422
The use of mRNA display to select high-affinity protein-binding peptides
Wilson, D. S., Keefe, A. D., & Szostak, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061028198 · Cited by 416
[21] Phage display for selection of novel binding peptides
Sidhu, S. S., Lowman, H. B., Cunningham, B. C., & Wells, J. A. (2000) · Methods in Enzymology · doi:10.1016/s0076-6879(00)28406-1 · Cited by 406
Mendez, M. J., Green, L. L., Corvalan, J. R. F., Jia, X.-C., Maynard-Currie, C. E., Yang, X.-D., Gallo, M. L., Louie, D. M., Lee, D. V., Erickson, K. L., et al. (1997) · Nature Genetics · doi:10.1038/ng0297-146 · Cited by 376
Fellouse, F. A., Esaki, K., Birtalan, S., Raptis, D., Cancasci, V. J., Koide, A., Jhurani, P., Vasser, M., Wiesmann, C., Kossiakoff, A. A., et al. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.08.005 · Cited by 358
Phage display technology: clinical applications and recent innovations
Azzazy, H. M. E., & Highsmith, W. E. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00343-0 · Cited by 351
BIACORE Analysis of Histidine-Tagged Proteins Using a Chelating NTA Sensor Chip
Nieba, L., Nieba-Axmann, S. E., Persson, A., Hämäläinen, M., Edebratt, F., Hansson, A., Lidholm, J., Magnusson, K., Karlsson, Å. F., & Plückthun, A. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2326 · Cited by 349
Phage display-derived human antibodies in clinical development and therapy
Frenzel, A., Schirrmann, T., & Hust, M. (2016) · mAbs · doi:10.1080/19420862.2016.1212149 · Cited by 346
Schwesinger, F., Ros, R., Strunz, T., Anselmetti, D., Güntherodt, H.-J., Honegger, A., Jermutus, L., Tiefenauer, L., & Plückthun, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.9972 · Cited by 343
Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries
Söderlind, E., Strandberg, L., Jirholt, P., Kobayashi, N., Alexeiva, V., Åberg, A.-M., Nilsson, A., Jansson, B., Ohlin, M., Wingren, C., et al. (2000) · Nature Biotechnology · doi:10.1038/78458 · Cited by 337
Antibody‐Conjugated Nanoparticles for Biomedical Applications
Arruebo, M., Valladares, M., & González-Fernández, Á. (2009) · Journal of Nanomaterials · doi:10.1155/2009/439389 · Cited by 331
Biophysical Properties of Human Antibody Variable Domains
Ewert, S., Huber, T., Honegger, A., & Plückthun, A. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01237-8 · Cited by 330
New protein engineering approaches to multivalent and bispecific antibody fragments
Plückthun, A., & Pack, P. (1997) · Immunotechnology · doi:10.1016/s1380-2933(97)00067-5 · Cited by 322
Exploiting recombination in single bacteria to make large phage antibody libraries
Sblattero, D., & Bradbury, A. (2000) · Nature Biotechnology · doi:10.1038/71958 · Cited by 316
Pukac, L., Kanakaraj, P., Humphreys, R., Alderson, R., Bloom, M., Sung, C., Riccobene, T., Johnson, R., Fiscella, M., Mahoney, A., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602487 · Cited by 306
Self-citationWaibel, R., Alberto, R., Willuda, J., Finnern, R., Schibli, R., Stichelberger, A., Egli, A., Abram, U., Mach, J.-P., Plückthun, A., et al. (1999) · Nature Biotechnology · doi:10.1038/12890 · Cited by 303
RNA Display Methods for the Discovery of Bioactive Macrocycles
Huang, Y., Wiedmann, M. M., & Suga, H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00430 · Cited by 298
Antibodies from phage antibody libraries
Bradbury, A. R. M., & Marks, J. D. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.04.007 · Cited by 296
Recent Developments in Protein Microarray Technology
Wilson, D. S., & Nock, S. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390150 · Cited by 294
Vaisman-Mentesh, A., Gutierrez-Gonzalez, M., DeKosky, B. J., & Wine, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01951 · Cited by 292
Hanes, J., Jermutus, L., Weber-Bornhauser, S., Bosshard, H. R., & Plückthun, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14130 · Cited by 290
Neri, D., Carnemolla, B., Nissim, A., Leprini, A., Querzè, G., Balza, E., Pini, A., Tarli, L., Halin, C., Neri, P., et al. (1997) · Nature Biotechnology · doi:10.1038/nbt1197-1271 · Cited by 282
Bennett, F., Luxenberg, D., Ling, V., Wang, I.-M., Marquette, K., Lowe, D., Khan, N., Veldman, G., Jacobs, K. A., Valge-Archer, V. E., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.711 · Cited by 281
Versatile strategy for controlling the specificity and activity of engineered T cells
Ma, J. S. Y., Kim, J. Y., Kazane, S. A., Choi, S.-H., Yun, H. Y., Kim, M. S., Rodgers, D. T., Pugh, H. M., Singer, O., Sun, S. B., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524193113 · Cited by 273
Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
Alfaleh, M. A., Alsaab, H. O., Mahmoud, A. B., Alkayyal, A. A., Jones, M. L., Mahler, S. M., & Hashem, A. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01986 · Cited by 273
Efficient Selection of DARPins with Sub-nanomolar Affinities using SRP Phage Display
Steiner, D., Forrer, P., & Plückthun, A. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.085 · Cited by 271
Molecular imaging with nanoparticles: giant roles for dwarf actors
Debbage, P., & Jaschke, W. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0511-y · Cited by 264
Applications of single-chain variable fragment antibodies in therapeutics and diagnostics
Weisser, N. E., & Hall, J. C. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2009.04.004 · Cited by 261
Efficient tumor targeting by single‐domain antibody fragments of camels
Cortez‐Retamozo, V., Lauwereys, M., Hassanzadeh Gh., G., Gobert, M., Conrath, K., Muyldermans, S., De Baetselier, P., & Revets, H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10212 · Cited by 260
Roschke, V., Sosnovtseva, S., Ward, C. D., Hong, J. S., Smith, R., Albert, V., Stohl, W., Baker, K. P., Ullrich, S., Nardelli, B., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4314 · Cited by 259
Antigen binding forces of individually addressed single-chain Fv antibody molecules
Ros, R., Schwesinger, F., Anselmetti, D., Kubon, M., Schäfer, R., Plückthun, A., & Tiefenauer, L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7402 · Cited by 253
Lee, C. V., Liang, W.-C., Dennis, M. S., Eigenbrot, C., Sidhu, S. S., & Fuh, G. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.05.051 · Cited by 227
Phage display of combinatorial antibody libraries
Rader, C., & Barbas, C. F. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80075-4 · Cited by 220
Maurer, J., Jose, J., & Meyer, T. F. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.3.794-804.1997 · Cited by 216
Targeted Intracellular Delivery of Antibodies: The State of the Art
Slastnikova, T. A., Ulasov, A. V., Rosenkranz, A. A., & Sobolev, A. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01208 · Cited by 215
Affimer proteins are versatile and renewable affinity reagents
Tiede, C., Bedford, R., Heseltine, S. J., Smith, G., Wijetunga, I., Ross, R., AlQallaf, D., Roberts, A. P., Balls, A., Curd, A., et al. (2017) · eLife · doi:10.7554/elife.24903 · Cited by 203
“Phage display has also been used to isolate antibody fragments (Dörsam et al., 1997; Vaughan et al., 1996) and lipocalins that recognise small molecules (Beste et al., 1999; Schlehuber et al., 2000).”
The Periplasmic Escherichia coli Peptidylprolyl cis,trans-Isomerase FkpA
Bothmann, H., & Plückthun, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910233199 · Cited by 192
Phage-displayed Antibody Libraries of Synthetic Heavy Chain Complementarity Determining Regions
Sidhu, S. S., Li, B., Chen, Y., Fellouse, F. A., Eigenbrot, C., & Fuh, G. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.050 · Cited by 172
Optimization of electroporation-mediated transformation: Staphylococcus carnosus as model organism
Löfblom, J., Kronqvist, N., Uhlén, M., Ståhl, S., & Wernérus, H. (2007) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2006.03127.x · Cited by 168
“Gram-negative systems have hitherto been the bacterial approach of choice, primarily owing to the reasonably high transformation frequencies obtained on a routine basis, enabling the construction of large libraries containing 10(9)–10(10) library members (Vaughan et al. 1996).”
BackgroundDrugs derived from phage display: From candidate identification to clinical practice
Nixon, A. E., Sexton, D. J., & Ladner, R. C. (2014) · mAbs · doi:10.4161/mabs.27240 · Cited by 167
Antibody Engineering for the Development of Therapeutic Antibodies
Kim, S. J., Park, Y., & Hong, H. J. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)25245-0 · Cited by 167
Functional heavy-chain antibodies in camelidae
Nguyen, V. K., Desmyter, A., & Muyldermans, S. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)79006-2 · Cited by 165
Fully human therapeutic monoclonal antibodies.
Weiner, L. M. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000192105.24583.83 · Cited by 164
Measuring the sequence-affinity landscape of antibodies with massively parallel titration curves
Adams, R. M., Mora, T., Walczak, A. M., & Kinney, J. B. (2016) · eLife · doi:10.7554/elife.23156 · Cited by 137
“Many high-throughput techniques, including phage display (Smith, 1985; Vaughan et al., 1996; Schirrmann et al., 2011), ribosome display (Fujino et al.”
BackgroundDillon, M., Yin, Y., Zhou, J., McCarty, L., Ellerman, D., Slaga, D., Junttila, T. T., Han, G., Sandoval, W., Ovacik, M. A., et al. (2017) · mAbs · doi:10.1080/19420862.2016.1267089 · Cited by 75
Ebert, T., Smith, S., Pancari, G., Clark, D., Hampton, R., Secore, S., Towne, V., Fan, H., Wang, X.-M., Wu, X., et al. (2010) · Human Antibodies · doi:10.3233/hab-2010-0235 · Cited by 50
Advances in the production and batch reformatting of phage antibody libraries
Reader, R. H., Workman, R. G., Maddison, B. C., & Gough, K. C. (2019) · Molecular Biotechnology · doi:10.1007/s12033-019-00207-0 · Cited by 41
Metadata
- Authors
- Vaughan, T. J., Williams, A. J., Pritchard, K., Osbourn, J. K., Pope, A. R., Earnshaw, J. C., McCafferty, J., Hodits, R. A., Wilton, J., & Johnson, K. S.
- Venue
- Nature Biotechnology
- Published
- 1996-03
- Volume
- 14
- Issue
- 3
- Pages
- 309-314
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2006174330
- Cited by
- 1,027
- References
- 34
- FWCI
- 67.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.